Volume 1 Number 3
Website Exclusive Contents!
Editorial
40
Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. - Does delayed neointimal growth exist?EuroInterv.2005;1:253-255
41
Magnetic wire navigation in PCI: Should magnetism "attract" the interventionalist's attention?EuroInterv.2005;1:256-259
Working group 10 column
Clinical research
44
One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings(The SPIRIT FIRST Trial)
Tsuchida K, Piek J, Neumann F-J, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm C, Veldhof S, Dorange C, Serruys PW
EuroInterv.2005;1:266-272
45
Randomized comparison of deliverability and in-hospital complications in implantation of BxSonic™, Express™ and Flexmaster™ coronary stentsThuesen L, Galløe A, Thayssen P, Rasmussen K, Kelbæk H, Lassen J, Hansen P, Pedersen K, Ravkilde J, Helqvist S, Abildgaard U, Andersen H, Bøtker H, Kristensen SD, Hjort J, Romer Krusell L
EuroInterv.2005;1:273-276
46
One year effectiveness of BiodivYsio dexamethazone-eluting stent compared to BiodivYsio stent implantation in the treatment of single vessel coronary artery diseaseEuroInterv.2005;1:277-281
47
First-in-man prospective evaluation of temporal changes in coronary plaque composition by in vivo intravascular ultrasound radiofrequency data analysis: an Integrated Biomarker and Imaging Study (IBIS) substudyRodríguez-Granillo G, Serruys PW, McFadden E, van Mieghem CAG, Goedhart D, Bruining N, van der Steen A, van der Giessen WJ, de Jaegere P, Vince D, Sianos G, Kaplow J, Zalewski A, de Feyter PJ
EuroInterv.2005;1:282-288
48
Carotid angioplasty and stenting: lesion related treatment strategiesCremonesi A, Setacci C, Manetti R, de Donato G, Setacci F, Balestra G, Borghesi I, Bianchi P, Castriota F
EuroInterv.2005;1:289-295
49
Treatment planning in patients with PAOD: Comparison of CE-MRA employing a dedicated peripheral MRA coil and high dose single volume contrast material application with i.a. DSA.EuroInterv.2005;1:296-304
50
Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot studyEuroInterv.2005;1:305-308
51
Time-to-reperfusion therapy influences outcome of patients with myocardial infarction subjected to facilitated PCIDudek D, Dziewierz A, Rakowski T, El Masri N, Sorysz D, Zalewski J, Legutko J, Zmudka K, Piwowarska W, Dubiel J
EuroInterv.2005;1:309-314
52
Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable anginaEuroInterv.2005;1:315-320
Magnetic navigation
54
Feasibility and safety of guidewire navigation using a magnetic navigation system in coronary artery stenosesK.Tsuchida , García-García H, Tanimoto S, Ong ATL, Sehra R, van der Ent M, Sianos G, van der Giessen WJ, Serruys PW
EuroInterv.2005;1:329-335
55
Use of the novel magnetic navigation system Niobe™ in percutaneous coronary interventions; the Hamburg experienceEuroInterv.2005;1:336-339
56
Concept, design and pre-clinical studies for remote control percutaneous coronary interventionsEuroInterv.2005;1:340-345
New device
57
Percutaneous Transvenous Mitral Annuloplasty (PTMA) with the Viking device reduces pacing-induced mitral regurgitationEuroInterv.2005;1:346-351
Expert review
58
Adjunctive Antiplatelet / Antithrombotic therapy in percutaneous coronary interventionEuroInterv.2005;1:352-357
59
Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy: current statusEuroInterv.2005;1:358-366
Image in cardiology
60
Detection of a necrotic core-rich, highly deformable plaque in an angiographically non-diseased proximal LADEuroInterv.2005;1:367
Volume 1 Number 3 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Boston Scientific
- Cordis, a Johnson & Johnson company
- Guidant
- Medtronic
- Terumo


